The Sales & Marketing Effectiveness in Chemicals Forum will bring together industry leaders as well as experts responsible and deeply involved in sales and marketing strategies.
Unveiling the 9th PPM Conference
Fleming. is one of the largest producers of Pharma/Biotech think tanks, debates and strategy sessions. We are well-recognized in North America, Europe and the Middle East as several of our events have taken place in Europe, Amsterdam, Rome and Barcelona.
We have worked with the top 100 Pharma and Biotech firms on various projects over the last decade and I am excited to unveil the 9th PPM Conference, Philadelphia, March 09-10, 2016.
Before writing the program of the 9th PPM Conference, I read about the PPM events happening in the USA, and I noticed that none of our competitors were providing a strategic view to the participants; hence, I decided to introduce a CEO Panel discussion, the very first in the PPM events landscape!
The CEO Panel enables participants to engage in discussions directly with CEOs from the Pharma and Biotech sectors to understand what they could do better, hear the CEOs' answers to the question of “is it the right time for Biotech buyouts?” Further, as I understood and probed further about the strategic PPM role, I built the conference around case studies and points of view. As you see through Day 1, we shall understand how to Connect Development Strategy to Both Budget and Operations. Sylke Poehling, who leads the pRED Strategy and Portfolio department at F. Hoffmann-La Roche Ltd, will demystify how to manage a portfolio of combinations and strengthen balance in a portfolio of combinations. Usman Iqbal, as part of both R&D and Med Affairs in different roles at AstraZeneca, has been responsible for Portfolio Prioritizations, Integrated Medical Affairs Planning and End-to-End Evidence Generation based on Stakeholder engagement (Patient, Provider, Payer), Market insights and Relative Medical Value Assessment Platforms. He will present deep insights into Leveraging Patient Centricity and Big Data to Prioritize Portfolio Development & Decision Making. Mike Shires from Baxalta will be presenting his point of view through Real-Life Lessons & Applications as well as by reviewing a Multi-Year Journey.
Day 2 is just as exciting! Andrea Kho from Abbvie will question whether we have missed the mark and how to be prepared for the dynamic future. She is a 20-year veteran of the company, where she’s held several roles in Portfolio and Project Management across multiple therapeutic areas such as Renal, Infectious Disease and Neonatology. How good is your decision making as a PPM manager? Strategies for Good Decision Making and how to structure the decision-making process shall be covered by Sonia Bujas from Pfizer. Sonia Bujas is the Senior Director and Team Leader for the Portfolio Group in the Portfolio & Decision Analysis (PDA) group at Pfizer. As part of her responsibilities, she oversees end-to-end portfolio strategy; analysis and prioritization for both innovative and established portfolios; R&D benchmarking and metrics; as well as portfolio systems and portfolio decision-making, including incentives.
The speakers, who are practitioners themselves, are industry leaders in their respective fields and experts in portfolio and project management; leadership; and innovation to inspire and expand your horizons. Our team extends a warm welcome to you: let's learn, debate, ignite and inspire through knowledge sharing!
Interested in this topic?
Process Scale-Up in Pharma (Solid Dosage Forms)
The major objective of this course is to provide a detailed insight into the practical aspects and approaches of process scale-up for different unit operations and technologies.
Patient Adherence and Engagement
Discuss the issues of non-adherence with other stakeholders and find a solution together with the patients themselves.
Next Generation Antibody Therapeutics
This focused 2-day training will cover the discovery, engineering and production of next-generation antibodies, antibody fragments, bispecific Abs, innovative ADCs and more. Follow the path from their discovery and selection through engineering and expression to production and regulatory issues.
Turning Patient Feedback to Meaningful Resource for Care Delivery
Read the interview with Nasser Al Naimi, Deputy Chief Quality Officer at Hamad Medical Corporation, and Co-Director at Hamad Healthcare Quality Institute, and learn how to turn your data into strategic information to drive patient-family centered care.
Creating & Leading Patient Experience Excellence
Read the full interview with Dr. Ahmed Mohammad Abu-Abah, CEO at King Abdullah BinAbdulaziz University Hospital and gain insight into the creating & leading patient experience excellence.
Excelling in PV is not only about Technical Expertise
For a PV leader, to be successful can look like a daily Herculean work: meeting a crucial mandate to minimize harm to patients, while ensuring that a product is prescribed to the right population, and maintaining the highest level of compliance within a very complex set of worldwide regulations.